Correction: Sequencing as a first-line methodology for cystic fibrosis carrier screening

類似資料

• Sequencing as a first-line methodology for cystic fibrosis carrier screening
  著者:: Beauchamp, Kyle A., 等
  出版事項: (2019)
• Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen
  著者:: Beauchamp, Kyle A., 等
  出版事項: (2019)
• Fragile X syndrome carrier screening accompanied by genetic consultation has clinical utility in populations beyond those recommended by guidelines
  著者:: Johansen Taber, Katherine, 等
  出版事項: (2019)
• Clinical utility of expanded carrier screening: results-guided actionability and outcomes
  著者:: Johansen Taber, Katherine A., 等
  出版事項: (2018)
• A data-driven evaluation of the size and content of expanded carrier screening panels
  著者:: Ben-Shachar, Rotem, 等
  出版事項: (2019)